Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pickering

Showing results (211-220 of 225) with videos related to

Pageof 23
Sort By:
ACS Chemical Neuroscience|May 25, 2019
Design and Synthesis of 2,3- trans-Proline Analogues as Ligands for Ionotropic Glutamate Receptors and Excitatory Amino Acid TransportersChristian B M Poulie, Anna Alcaide, Mikkel Krell-Jørgensen, et al.
ACS Chemical Neuroscience|October 18, 2019
<i>N</i>-(7-(1<i>H</i>-Imidazol-1-yl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2<i>H</i>)-yl)benzamide, a New Kainate Receptor Selective Antagonist and Analgesic: Synthesis, X-ray Crystallography, Structure-Affinity Relationships, and in Vitro and in Vivo PharmacologyStine Møllerud, Rie B Hansen, Jakob Pallesen, et al.
Journal of Medicinal Chemistry|February 17, 2018
( S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: Further Exploration of Bioisosteric Replacements and Structural and Biological InvestigationSimone Brogi, Margherita Brindisi, Stefania Butini, et al.
Journal of Medicinal Chemistry|July 11, 2009
The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterizationRasmus P Clausen, Peter Naur, Anders S Kristensen, et al.
Neuropathology and Applied Neurobiology|November 6, 2015
Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteinsY Davidson, A C Robinson, X Liu, et al.
Systematic Reviews|September 22, 2023
Increasing the transparency of systematic reviews: presenting a generalized registration formOlmo R van den Akker, Gjalt-Jorn Ygram Peters, Caitlin J Bakker, et al.
Infection Prevention in Practice|November 23, 2021
Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19B Merrick, M Noronha, R Batra, et al.
Transboundary and Emerging Diseases|April 30, 2025
Surveillance for SARS-CoV-2 in Norway Rats (<i>Rattus norvegicus</i>) from Southern OntarioSarah J Robinson, Jonathon D Kotwa, Simon P Jeeves, et al.
The Lancet. Microbe|May 11, 2022
Towards a coordinated strategy for intercepting human disease emergence in AfricaKristian M Forbes, Omu Anzala, Colin J Carlson, et al.
Molecular and Cellular Neurosciences|December 31, 2003
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric diseaseS M Harrison, C Reavill, G Brown, et al.
Pageof 23

Showing results (211-220 of 225) with videos related to

Sort By:
Pageof 23
ACS Chemical Neuroscience|May 25, 2019
Design and Synthesis of 2,3- trans-Proline Analogues as Ligands for Ionotropic Glutamate Receptors and Excitatory Amino Acid TransportersChristian B M Poulie, Anna Alcaide, Mikkel Krell-Jørgensen, et al.
ACS Chemical Neuroscience|October 18, 2019
<i>N</i>-(7-(1<i>H</i>-Imidazol-1-yl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2<i>H</i>)-yl)benzamide, a New Kainate Receptor Selective Antagonist and Analgesic: Synthesis, X-ray Crystallography, Structure-Affinity Relationships, and in Vitro and in Vivo PharmacologyStine Møllerud, Rie B Hansen, Jakob Pallesen, et al.
Journal of Medicinal Chemistry|February 17, 2018
( S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: Further Exploration of Bioisosteric Replacements and Structural and Biological InvestigationSimone Brogi, Margherita Brindisi, Stefania Butini, et al.
Journal of Medicinal Chemistry|July 11, 2009
The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterizationRasmus P Clausen, Peter Naur, Anders S Kristensen, et al.
Neuropathology and Applied Neurobiology|November 6, 2015
Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteinsY Davidson, A C Robinson, X Liu, et al.
Systematic Reviews|September 22, 2023
Increasing the transparency of systematic reviews: presenting a generalized registration formOlmo R van den Akker, Gjalt-Jorn Ygram Peters, Caitlin J Bakker, et al.
Infection Prevention in Practice|November 23, 2021
Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19B Merrick, M Noronha, R Batra, et al.
Transboundary and Emerging Diseases|April 30, 2025
Surveillance for SARS-CoV-2 in Norway Rats (<i>Rattus norvegicus</i>) from Southern OntarioSarah J Robinson, Jonathon D Kotwa, Simon P Jeeves, et al.
The Lancet. Microbe|May 11, 2022
Towards a coordinated strategy for intercepting human disease emergence in AfricaKristian M Forbes, Omu Anzala, Colin J Carlson, et al.
Molecular and Cellular Neurosciences|December 31, 2003
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric diseaseS M Harrison, C Reavill, G Brown, et al.
Pageof 23